We are live on ! Find out more
MXCT icon

MaxCyte

104 hedge funds and large institutions have $376M invested in MaxCyte in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 45 increasing their positions, 30 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 30

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

0.88% less ownership

Funds ownership: 68.42%67.54% (-0.88%)

10% less call options, than puts

Call options by funds: $19K | Put options by funds: $21K

4% less funds holding

Funds holding: 108104 (-4)

17% less capital invested

Capital invested by funds: $452M → $376M (-$76.4M)

36% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 11

Holders
104
Holders Change
-4
Holders Change %
-3.7%
% of All Funds
1.67%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
7
Increased
45
Reduced
30
Closed
11
Calls
$19K
Puts
$21K
Net Calls
-$2K
Net Calls Change
-$101K
Name Holding Trade Value Shares
Change
Change in
Stake
BCM
51
Bridgeway Capital Management
Texas
$553K
TA
52
Tamarack Advisers
California
$546K +$110K +17,901 +22%
California State Teachers Retirement System (CalSTRS)
53
California State Teachers Retirement System (CalSTRS)
California
$527K +$6.72K +1,096 +1%
AG
54
Algert Global
California
$504K +$297K +48,420 +110%
FAM
55
Fred Alger Management
New York
$501K
MA
56
Mudita Advisors
United Kingdom
$492K +$178K +28,967 +47%
SO
57
STRS Ohio
Ohio
$484K +$174K +28,300 +47%
Susquehanna International Group
58
Susquehanna International Group
Pennsylvania
$479K -$208K -33,968 -28%
UBS AM
59
UBS AM
Illinois
$343K
MIM
60
MetLife Investment Management
New Jersey
$306K
CS
61
Credit Suisse
Switzerland
$271K +$35.9K +5,857 +13%
UBS Group
62
UBS Group
Switzerland
$239K +$201K +32,770 +300%
Mirae Asset Global Investments
63
Mirae Asset Global Investments
South Korea
$229K +$264 +43 +0.1%
VA
64
Valmark Advisers
Ohio
$228K +$43.6K +7,118 +21%
AIG
65
American International Group
New York
$225K -$926 -151 -0.4%
Ensign Peak Advisors
66
Ensign Peak Advisors
Utah
$211K +$117K +19,050 +97%
DekaBank Deutsche Girozentrale
67
DekaBank Deutsche Girozentrale
Germany
$205K
Deutsche Bank
68
Deutsche Bank
Germany
$196K +$3.56K +581 +2%
AllianceBernstein
69
AllianceBernstein
Tennessee
$191K +$104K +17,000 +94%
GS
70
Gagnon Securities
New York
$188K +$211K +34,468 New
VOYA Investment Management
71
VOYA Investment Management
Georgia
$188K
Invesco
72
Invesco
Georgia
$187K -$448 -73 -0.2%
Manulife (Manufacturers Life Insurance)
73
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$182K -$3.78K -616 -2%
SG Americas Securities
74
SG Americas Securities
New York
$172K -$5.92K -965 -3%
Barclays
75
Barclays
United Kingdom
$167K +$119K +19,377 +173%

MXCT Hedge Fund Activity: Q4 2022 in Review

104 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q4 2022, worth a combined $376M — down 17% from $452M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of MXCT and 7 opened new positions — a net loss of 4 holders — while 30 trimmed existing stakes and 45 added.

The largest buyer was Citadel Advisors, adding an estimated $5.93M. The largest seller was Casdin Capital, cutting an estimated $7.55M.

  • 104 institutional investors held MaxCyte (MXCT) as of Q4 2022, down from 108 in Q3 2022.
  • Funds reported $376M of MaxCyte stock for Q4 2022, down 17% quarter-over-quarter.
  • 7 funds opened new MaxCyte positions in Q4 2022 and 11 closed out, a net change of -4 holders.
  • The largest MaxCyte buyer in Q4 2022 was Citadel Advisors, an estimated $5.93M added.
  • The largest MaxCyte seller in Q4 2022 was Casdin Capital, an estimated $7.55M sold.

Based on aggregated 13F filings for Q4 2022.